Shiva Shahrara Selected Research

Bleomycin (Blenoxane)

9/2009

Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiva Shahrara Research Topics

Disease

32	Rheumatoid Arthritis 07/2022 - 01/2002
17	Arthritis (Polyarthritis) 01/2022 - 12/2003
15	Inflammation (Inflammations) 07/2022 - 12/2003
9	Experimental Arthritis 01/2022 - 04/2010
7	Osteoarthritis 01/2021 - 01/2002
5	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 10/2011
3	Hypoxia (Hypoxemia) 01/2022 - 10/2015
2	COVID-19 01/2021 - 01/2021
2	Psoriatic Arthritis 01/2021 - 04/2011
2	Obesity 08/2018 - 01/2017
2	Prostatitis 10/2010 - 05/2008
2	Pelvic Pain 10/2010 - 05/2008
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Synovitis 01/2021
1	Necrosis 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Infections 01/2014
1	Neoplasms (Cancer) 01/2014
1	Spinal Diseases (Disease, Spinal) 01/2014
1	Chronic Disease (Chronic Diseases) 05/2013
1	Multiple Sclerosis 10/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2011
1	Hypertrophy 08/2011
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2011
1	Fibrosis (Cirrhosis) 09/2009
1	Wounds and Injuries (Trauma) 09/2009
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2008
1	Pain (Aches) 05/2008
1	Pathologic Neovascularization 08/2007

Drug/Important Bio-Agent (IBA)

10	ChemokinesIBA 04/2020 - 10/2006
10	CytokinesIBA 10/2015 - 06/2005
8	Interleukin-17 (Interleukin 17)IBA 10/2020 - 03/2009
5	LigandsIBA 01/2021 - 01/2002
4	Interleukin-7 (Interleukin 7)IBA 07/2022 - 10/2011
4	EnzymesIBA 01/2014 - 06/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
3	Interleukin-27 (Interleukin 27)IBA 04/2013 - 01/2008
3	ImmunosorbentsIBA 04/2011 - 06/2005
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2010 - 03/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2014
2	Interleukin-12 (IL 12)IBA 01/2021 - 04/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2017 - 01/2017
2	Toll-Like Receptor 7IBA 01/2016 - 03/2013
2	InterleukinsIBA 10/2015 - 01/2008
2	Immunoglobulin G (IgG)IBA 05/2013 - 12/2011
2	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 05/2013 - 10/2011
2	Chemokine CCL5IBA 03/2008 - 10/2006
2	Messenger RNA (mRNA)IBA 03/2006 - 12/2003
2	CC ChemokinesIBA 06/2005 - 12/2003
2	Chemokine ReceptorsIBA 06/2005 - 12/2003
1	Estrogens (Estrogen)FDA Link 01/2022
1	PPAR gammaIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Pyruvic Acid (Pyruvate)IBA 11/2021
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 11/2021
1	Syndecan-1 (Syndecan 1)IBA 11/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	MonokinesIBA 01/2021
1	LymphokinesIBA 01/2021
1	tofacitinibIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	ArginaseIBA 01/2020
1	Interleukin-11 (Interleukin 11)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Toll-Like Receptor 4IBA 10/2015
1	Matrix Metalloproteinases (MMPs)IBA 10/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	tocilizumab (atlizumab)FDA Link 01/2014
1	Toll-Like Receptor 5IBA 08/2013
1	FlagellinIBA 08/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	Neutralizing AntibodiesIBA 12/2011
1	C-Reactive ProteinIBA 10/2011
1	Chemotactic FactorsIBA 10/2010
1	Interleukin-18 (Interleukin 18)IBA 01/2010
1	ZymosanIBA 01/2010
1	CollagenIBA 09/2009
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2009
1	Transcription Factors (Transcription Factor)IBA 09/2009
1	Biomarkers (Surrogate Marker)IBA 05/2008
1	CCR5 Receptors (CCR5 Receptor)IBA 03/2008
1	Interleukin-23 (Interleukin 23)IBA 01/2008
1	InterferonsIBA 01/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2007
7	Ligation 01/2022 - 03/2013
1	Biological Therapy 01/2021
1	Continuity of Patient Care 01/2021
1	Organ Transplantation 01/2014